Evidence map›Paper›PMID 41792433›Full record

ArticleScientific reports2026

Three-dimensional reconstruction of ediacaran ceramiales (Rhodophyta) from the phosphorite doushantuo formation, South China.

Wei Du, Xunlian Wang, Yue Wang, Kentaro Uesugi, Masahiro Yasutake, Tsuyoshi Komiya

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wei DuGraduate School of Arts and Sciences, The University of Tokyo, Tokyo, 153-8902, Japan. duwei@g.ecc.u-tokyo.ac.jp.
Xunlian WangSchool of Earth Sciences and Resources, China University of Geosciences, Beijing, 100083, China.
Yue WangSchool of Resource and Environment, Guizhou University, Guiyang, 550003, China.
Kentaro UesugiJapan Synchrotron Radiation Research Institute (JASRI), 1-1-1 Kouto, Sayo-Cho, Sayo-Gun, Hyogo, 679-5198, Japan.
Masahiro YasutakeJapan Synchrotron Radiation Research Institute (JASRI), 1-1-1 Kouto, Sayo-Cho, Sayo-Gun, Hyogo, 679-5198, Japan.
Tsuyoshi KomiyaGraduate School of Arts and Sciences, The University of Tokyo, Tokyo, 153-8902, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Ediacaran Doushantuo Formation (551-635 Ma) is known to include excellently preserved microfossils that reveal information about early eukaryotic evolution. Here, we report the presence of Vetusceramium sinense gen. et sp. nov., a new multicellular red algal fossil from the Weng'an Phosphorite Member of the Doushantuo Formation, South China. Reconstruction of the fossils using synchrotron X-ray tomography shows that these specimens bear a multilayered uniaxial thallus comprising a large central axial cell, pericentral corticated cell filaments, and possible pit connections, which bear similarity to the branches of modern Ceramiales belonging to Rhodophyta. However, the absence of reproductive features, such as gametangia, prevents crown group classification, suggesting a stem group affinity within the Ceramiales. This evidence suggests the possibility of pushing back the occurrence of Ceramiales-like multicellularity to the late Ediacaran Period, demonstrating sophisticated developmental strategies in early photoautotrophs. This report highlights the importance of phosphatization in uncovering subcellular details and offers key insights into the evolution of red algae before the Cambrian radiation.

Indexed as

FossilsImaging, Three-DimensionalRhodophytaChinaPhylogenyCeramialesDoushantuo formationEdiacaranRhodophyta

Identifiers

PMID41792433
PMCPMC13021990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.